Stay updated on INTRINSIC Clinical Trial: Tailored Metastatic CRC Therapies

Sign up to get notified when there's something new on the INTRINSIC Clinical Trial: Tailored Metastatic CRC Therapies page.
Latest website image capture
Clouds background image

Latest updates to the INTRINSIC Clinical Trial: Tailored Metastatic CRC Therapies page

  1. Check
    yesterday
    Change Detected
    Summary
    The page has updated its date references, removing some past dates and adding new ones, indicating a shift in scheduling or availability. Additionally, the status has changed to 'Suspended', which may affect user engagement or service availability.
    Difference
    0.4%
    Check dated 2025-05-08T13:51:52.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-01T06:22:13.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The webpage has been updated to include new drug names related to metastatic colorectal cancer, such as Atezolizumab, Tiragolumab, and others, while significant details about the study's design and eligibility criteria have been removed.
    Difference
    20%
    Check dated 2025-04-16T20:42:02.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The page has updated its revision number to v2.14.4 and changed its status to 'Active, not recruiting'. Additionally, the date has been updated to 2025-04-06.
    Difference
    0.7%
    Check dated 2025-04-09T15:05:56.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new last update date of March 25, 2025, and a revision change to version 2.14.3, replacing the previous date of March 10, 2025, and version 2.14.2.
    Difference
    0.1%
    Check dated 2025-04-02T00:23:04.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The study has increased its locations from 72 to 73 and has changed its status from 'Active, not recruiting' to 'Completed'.
    Difference
    0.8%
    Check dated 2025-03-11T08:40:20.000Z thumbnail image

Stay in the know with updates to INTRINSIC Clinical Trial: Tailored Metastatic CRC Therapies

Enter your email address, and we'll notify you when there's something new on the INTRINSIC Clinical Trial: Tailored Metastatic CRC Therapies page.